238 related articles for article (PubMed ID: 30047979)
1. Transcriptional activation of ENPP1 by osterix in osteoblasts and osteocytes.
Gao MM; Su QN; Liang TZ; Ma JX; Liang TZ; Stoddart MJ; Richards RG; Zhou ZY; Zou NX
Eur Cell Mater; 2018 Jul; 36():1-14. PubMed ID: 30047979
[TBL] [Abstract][Full Text] [Related]
2. Antagonistic interactions between osterix and pyrophosphate during cementum formation.
Choi H; Liu Y; Jeong JK; Kim TH; Cho ES
Bone; 2019 Aug; 125():8-15. PubMed ID: 31059863
[TBL] [Abstract][Full Text] [Related]
3. Inorganic pyrophosphatase induces type I collagen in osteoblasts.
Polewski MD; Johnson KA; Foster M; Millán JL; Terkeltaub R
Bone; 2010 Jan; 46(1):81-90. PubMed ID: 19733704
[TBL] [Abstract][Full Text] [Related]
4. Upregulated osterix expression elicited by Runx2 and Dlx5 is required for the accelerated osteoblast differentiation in PP2A Cα-knockdown cells.
Yang D; Okamura H; Qiu L
Cell Biol Int; 2018 Apr; 42(4):403-410. PubMed ID: 29068100
[TBL] [Abstract][Full Text] [Related]
5. Comparative immunolocalization of tissue nonspecific alkaline phosphatase and ectonucleotide pyrophosphatase/phosphodiesterase 1 in murine bone.
Yamamoto T; Hasegawa T; Mae T; Hongo H; Yamamoto T; Abe M; Nasoori A; Morimoto Y; Maruoka H; Kubota K; Haraguchi M; Li M
J Oral Biosci; 2021 Sep; 63(3):259-264. PubMed ID: 34391947
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of Macf1 in osterix expressing cells decreases bone formation by Bmp2/Smad/Runx2 pathway.
Qiu WX; Ma XL; Lin X; Zhao F; Li DJ; Chen ZH; Zhang KW; Zhang R; Wang P; Xiao YY; Miao ZP; Dang K; Wu XY; Qian AR
J Cell Mol Med; 2020 Jan; 24(1):317-327. PubMed ID: 31709715
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the osterix (Osx, Sp7) promoter by osterix and its inhibition by parathyroid hormone.
Barbuto R; Mitchell J
J Mol Endocrinol; 2013; 51(1):99-108. PubMed ID: 23682129
[TBL] [Abstract][Full Text] [Related]
8. Mitogen-activated protein kinase (MAPK)-regulated interactions between Osterix and Runx2 are critical for the transcriptional osteogenic program.
Artigas N; Ureña C; Rodríguez-Carballo E; Rosa JL; Ventura F
J Biol Chem; 2014 Sep; 289(39):27105-27117. PubMed ID: 25122769
[TBL] [Abstract][Full Text] [Related]
9. Osteoblast-specific transcription factor Osterix (Osx) is an upstream regulator of Satb2 during bone formation.
Tang W; Li Y; Osimiri L; Zhang C
J Biol Chem; 2011 Sep; 286(38):32995-3002. PubMed ID: 21828043
[TBL] [Abstract][Full Text] [Related]
10. ENPP1 deletion causes mouse osteoporosis via the MKK3/p38 MAPK/PCNA signaling pathway.
Wang Q; Gao Z; Guo K; Lu J; Wang F; Huang Y; Wu D
J Orthop Surg Res; 2022 Oct; 17(1):455. PubMed ID: 36243801
[TBL] [Abstract][Full Text] [Related]
11. Ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) protein regulates osteoblast differentiation.
Nam HK; Liu J; Li Y; Kragor A; Hatch NE
J Biol Chem; 2011 Nov; 286(45):39059-71. PubMed ID: 21930712
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of bone sialoprotein gene expression by Osx.
Yang Y; Huang Y; Zhang L; Zhang C
Biochem Biophys Res Commun; 2016 Aug; 476(4):574-579. PubMed ID: 27261434
[TBL] [Abstract][Full Text] [Related]
13. FGF2 stimulation of the pyrophosphate-generating enzyme, PC-1, in pre-osteoblast cells is mediated by RUNX2.
Hatch NE; Li Y; Franceschi RT
J Bone Miner Res; 2009 Apr; 24(4):652-62. PubMed ID: 19049325
[TBL] [Abstract][Full Text] [Related]
14. Mg
Wang Z; Liu Q; Liu C; Tan W; Tang M; Zhou X; Sun T; Deng Y
J Cell Physiol; 2020 Jun; 235(6):5182-5191. PubMed ID: 31742679
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase 13 (MMP13) is a direct target of osteoblast-specific transcription factor osterix (Osx) in osteoblasts.
Zhang C; Tang W; Li Y
PLoS One; 2012; 7(11):e50525. PubMed ID: 23185634
[TBL] [Abstract][Full Text] [Related]
16. SIRT7 has a critical role in bone formation by regulating lysine acylation of SP7/Osterix.
Fukuda M; Yoshizawa T; Karim MF; Sobuz SU; Korogi W; Kobayasi D; Okanishi H; Tasaki M; Ono K; Sawa T; Sato Y; Chirifu M; Masuda T; Nakamura T; Tanoue H; Nakashima K; Kobashigawa Y; Morioka H; Bober E; Ohtsuki S; Yamagata Y; Ando Y; Oike Y; Araki N; Takeda S; Mizuta H; Yamagata K
Nat Commun; 2018 Jul; 9(1):2833. PubMed ID: 30026585
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 and extracellular calcium promote mineral deposition via NPP1 activity in a mature osteoblast cell line MLO-A5.
Yang D; Turner AG; Wijenayaka AR; Anderson PH; Morris HA; Atkins GJ
Mol Cell Endocrinol; 2015 Sep; 412():140-7. PubMed ID: 26054750
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of Vascular Endothelial Growth Factor (VEGF) by osteoblast-specific transcription factor Osterix (Osx) in osteoblasts.
Tang W; Yang F; Li Y; de Crombrugghe B; Jiao H; Xiao G; Zhang C
J Biol Chem; 2012 Jan; 287(3):1671-8. PubMed ID: 22110141
[TBL] [Abstract][Full Text] [Related]
19. Osterix and RUNX2 are Transcriptional Regulators of Sclerostin in Human Bone.
Pérez-Campo FM; Santurtún A; García-Ibarbia C; Pascual MA; Valero C; Garcés C; Sañudo C; Zarrabeitia MT; Riancho JA
Calcif Tissue Int; 2016 Sep; 99(3):302-9. PubMed ID: 27154028
[TBL] [Abstract][Full Text] [Related]
20. Sclerostin is a direct target of osteoblast-specific transcription factor osterix.
Yang F; Tang W; So S; de Crombrugghe B; Zhang C
Biochem Biophys Res Commun; 2010 Oct; 400(4):684-8. PubMed ID: 20816666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
